Idexx Laboratories Overview
- Year Founded
-
1983
- Status
-
Public
- Employees
-
11,000
- Stock Symbol
-
IDXX
- Investments
-
35
- Share Price
-
$704.23
- (As of Friday Closing)
Idexx Laboratories General Information
Description
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
Contact Information
Website
www.idexx.comCorporate Office
- One Idexx Drive
- Westbrook, ME 04092
- United States
Corporate Office
- One Idexx Drive
- Westbrook, ME 04092
- United States
Idexx Laboratories Stock Performance
As of 13-Nov-2026, Idexx Laboratories’s stock price is $704.23. Its current market cap is $55.5B with 78.8M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $704.23 | $698.02 | $500.61 - $769.98 | $55.5B | 78.8M | 568K | $14.91 |
Idexx Laboratories Financials Summary
As of 30-Sep-2026, Idexx Laboratories has a trailing 12-month revenue of $4.66B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 42,037,859 | 54,926,617 | 34,544,039 | 46,906,316 |
| Revenue | 4,662,221 | 4,303,702 | 3,897,504 | 3,660,953 |
| EBITDA | 1,668,826 | 1,505,214 | 1,258,273 | 1,212,036 |
| Net Income | 1,182,191 | 1,059,464 | 887,867 | 845,042 |
| Total Assets | 3,707,109 | 3,350,759 | 3,293,443 | 3,259,925 |
| Total Debt | 972,963 | 976,062 | 986,948 | 1,067,353 |
Idexx Laboratories Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Idexx Laboratories Comparisons
Industry
Financing
Details
Idexx Laboratories Competitors (32)
One of Idexx Laboratories’s 32 competitors is Revvity, a Corporation company based in Waltham, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Revvity | Corporation | Waltham, MA | ||||
| BIONOTE | Formerly VC-backed | Hwaseong, South Korea | ||||
| Randox Laboratories | Corporation | Crumlin, United Kingdom | ||||
| Great Basin Scientific | Formerly VC-backed | West Valley City, UT | ||||
| Arkray | Corporation | Kyoto, Japan |
Idexx Laboratories Patents
Idexx Laboratories Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-D1144962-S1 | Lateral flow device | Active | 18-Jul-2025 | ||
| US-20260301924-A1 | Methods, systems, and devices for interpreting non-human patient medical images | Pending | 27-Mar-2025 | ||
| US-20260301956-A1 | Methods, systems, and devices for updating a veterinarian radiology worklist | Pending | 27-Mar-2025 | ||
| US-20260185991-A1 | Devices for detection and differentiation of renal disease | Pending | 31-Dec-2024 | ||
| US-20260188509-A1 | Systems and methods for identifying canine hypothyroidism | Pending | 31-Dec-2024 | G16H50/30 |
Idexx Laboratories Signals
Idexx Laboratories Investments & Acquisitions (35)
Idexx Laboratories’s most recent deal was a Merger/Acquisition with CoVet. The deal was made on 16-Sep-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| CoVet | 16-Sep-2026 | Merger/Acquisition | Other Services (B2C Non-Financial) | ||
| Greenline Pet | 31-Mar-2024 | Merger/Acquisition | Business/Productivity Software | ||
| TECTA-PDS | 25-Aug-2022 | Merger/Acquisition | Electronic Equipment and Instruments | ||
| Epocal | 12-Jan-2022 | Merger/Acquisition | Monitoring Equipment | ||
| IDEXX Laboratories (Reference Laboratory) | 01-Dec-2021 | Corporate Asset Purchase | Buildings and Property |
Idexx Laboratories ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
14.71 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Devices
Subindustry
of 209
Rank
Percentile
Idexx Laboratories Exits (2)
Idexx Laboratories’s most recent exit was on 30-Jan-1997 from Acumedia Manufacturers. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Acumedia Manufacturers | 30-Jan-1997 | Completed |
|
||
| Purisys | 22-Aug-1994 | Secondary Transaction - Private | Completed |
Idexx Laboratories Affiliates
Subsidiaries (13)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| CoVet | Hamilton, Canada | 2023 | |
| Vet Radar | Auckland, New Zealand | 2018 | |
| Greenline Pet | Memphis, TN | 2013 | |
| Movet (Other Services (B2C Non-Financial) | Kuopio, Finland | 2008 | |
| EzyVet | Auckland, New Zealand | 2006 |
Idexx Laboratories FAQs
-
When was Idexx Laboratories founded?
Idexx Laboratories was founded in 1983.
-
Where is Idexx Laboratories headquartered?
Idexx Laboratories is headquartered in Westbrook, ME.
-
What is the size of Idexx Laboratories?
Idexx Laboratories has 11,000 total employees.
-
What industry is Idexx Laboratories in?
Idexx Laboratories’s primary industry is Diagnostic Equipment.
-
Is Idexx Laboratories a private or public company?
Idexx Laboratories is a Public company.
-
What is Idexx Laboratories’s stock symbol?
The ticker symbol for Idexx Laboratories is IDXX.
-
What is the current stock price of Idexx Laboratories?
As of 13-Nov-2026 the stock price of Idexx Laboratories is $704.23.
-
What is the current market cap of Idexx Laboratories?
The current market capitalization of Idexx Laboratories is $55.5B.
-
What is Idexx Laboratories’s current revenue?
The trailing twelve month revenue for Idexx Laboratories is $4.66B.
-
Who are Idexx Laboratories’s competitors?
Revvity, BIONOTE, Randox Laboratories, Great Basin Scientific, and Arkray are some of the 32 competitors of Idexx Laboratories.
-
What is Idexx Laboratories’s annual earnings per share (EPS)?
Idexx Laboratories’s EPS for 12 months was $14.91.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process